[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ugt1a1-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"UGT1A1 Gene",4,3,[8,15,22,29],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05391126","GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care",[],"RECRUITING","2026-08-26T02:19:20.945539Z","2026-05-05T02:43:28.986728Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06072131","To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL",[19],"Phase 3","2026-08-26T02:18:01.700186Z","2026-05-05T02:43:28.181541Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT06406465","A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity",[26],"Phase 2","2026-08-26T02:18:22.309547Z","2026-05-05T02:43:27.055066Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT07349771","Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial",[26],"NOT_YET_RECRUITING","2026-08-26T02:15:01.639696Z","2026-05-05T02:43:27.262656Z"]